Bayer U.S. 🇺🇸

Official profile for Bayer in the United States. Advancing science that delivers for people in America. Health for All, Hunger for None is what drives us.

[Bayer U.S. 🇺🇸 @BayerUS]

Today the U.S. FDA approved our new medicine for secondary stroke risk reduction in adults, continuing our long-standing commitment to stroke care: https://t.co/n1A3rLP4mi

[Matthew Herper @matthewherper]

Bayer (a sponsor) brought a six-foot mailbox to #STATSummit. Me included for height comparison.

[Bayer U.S. 🇺🇸 @BayerUS]

+++NEWS+++ The U.S. has accepted Bayer’s supplemental New Drug Application for our investigational treatment for adults with chronic kidney disease (CKD) without diabetes.

Details here: https://t.co/TzSNW3SqOi

[Bayer U.S. 🇺🇸 @BayerUS]

Bayer plans to invest $2.2 billion in a new pharmaceutical manufacturing campus in New Albany, Ohio - bringing manufacturing closer to patients and supporting the reliable production of innovative medicines at scale.

Learn more: https://t.co/iivwSVJ97o

[Bayer U.S. 🇺🇸 @BayerUS]

+++NEWS+++ The U.S. Food and Drug Administration (FDA) has approved our treatment for adults with chronic kidney disease (CKD) associated with type 1 diabetes (T1D).

Learn more: https://t.co/lpcwZVQOUA

[Bayer U.S. 🇺🇸 @BayerUS]

@direncenjoyer01 Hello, we understand that One A Day® is a brand name and does not necessarily reflect the serving size of each product. For certain One A Day formulations, it may be necessary to take two tablets, caplets, or gummies to obtain the nutrient values listed in the Supplement Facts.

[Bayer U.S. 🇺🇸 @BayerUS]

#NEWS: Bayer today announced the U.S. FDA has accepted its new drug application (NDA) for its investigational treatment for the prevention of
secondary stroke. #TeamBayer #ScienceDelivers

Learn more: https://t.co/CmNyZQE6iK

[Bayer U.S. 🇺🇸 @BayerUS]

This #StrokeAwarnessMonth and #WomensHealthMonth, @guth_sebastian, Worldwide Chief Operating Officer for @BayerPharma, and @DrCCosby discuss secondary stroke prevention, the global burden of stroke, and its impact on patients. #ScienceDelivers

[Bayer U.S. 🇺🇸 @BayerUS]

What if American farms could help fuel the planes overhead and the trucks on the road? 🌾Bayer and @bp_plc are making it real – scaling newgold® camelina as a feedstock for renewable diesel and sustainable aviation fuel across North America.

https://t.co/1trxVr2B1G

[Bayer U.S. 🇺🇸 @BayerUS]

#TeamBayer presented new late-breaking data from our Phase III OCEANIC-STROKE study today at #ESOC2026. We are committed to sharing insights that help drive impact in this area of unmet need.

Learn more: https://t.co/OZMIDP5ZS9

[Bayer AG @Bayer]

#News: We intend to acquire Perfuse Therapeutics, a biopharmaceutical company focused on ischemia-induced ocular diseases. Acquisition complements our pharmaceutical pipeline & reinforces our commitment to developing urgently needed therapies for patients: https://t.co/feCeNRhD8S

[Bayer U.S. 🇺🇸 @BayerUS]

Each year, stroke affects millions worldwide and can lead to lasting effects, including impaired mobility and loss of speech or vision. Hear from @ChaturvediNeuro on the unmet needs in secondary stroke prevention.

#TeamBayer #StrokePrevention

[Bayer U.S. 🇺🇸 @BayerUS]

We‘re proud to see our secondary stroke prevention research published in @NEJM, initially presented at the International Stroke Congress 2026. This publication reflects our continued focus on advancing science for patients at risk of secondary stroke.

https://t.co/Ia65vjrrW9

[Bayer AG @Bayer]

Update on Roundup Litigation: Today, a proposed U.S. nationwide class settlement was announced, designed to resolve eligible current and future RoundupTM claims through a long-term claims program. More details can be found in the link below. https://t.co/nYS4cxH9iX

[Bayer U.S. 🇺🇸 @BayerUS]

Today #TeamBayer presented results from our Phase III OCEANIC-STROKE study at #ISC26. We’re excited to contribute the latest data in an area of unmet need for the stroke community.

Read more: https://t.co/ielmA3sFRf

[Bayer U.S. 🇺🇸 @BayerUS]

Come see us at #ISC26! #TeamBayer will be presenting results from our Phase III OCEANIC-STROKE study during two late-breaking sessions.

We are excited to contribute to the research in stroke care.

Learn more: https://t.co/C0T82j8T2p

[Bayer U.S. 🇺🇸 @BayerUS]

The U.S. Supreme Court today announced that it will review the Durnell Roundup case. The company expects a decision on the merits during the Court’s 2026 session, which ends in June.

Link to press release: https://t.co/tEu0S6L7HJ

[Bayer U.S. 🇺🇸 @BayerUS]

@HERMIT37 We're genuinely sorry to hear that our advertisement didn't resonate with you. Understanding your experience is incredibly important to us, and we truly value your perspective. Please rest assured that your feedback is of great significance.

[Bayer U.S. 🇺🇸 @BayerUS]

@jr3500 Hi JR. We're sorry you find the cotton so frustrating to remove. Cotton is placed in some bottles of Claritin to help minimize breakage of the product during shipment from the manufacturing plants to the store shelf. We appreciate the feedback and will share it with our team!

[Bayer U.S. 🇺🇸 @BayerUS]

@MrsNicholson925 Thank you for reaching out and sharing your experience. We sincerely apologize for the frustration. Your feedback is invaluable, and we’ll escalate this to our team to drive improvements.

To assist further, please share your details via our contact form. https://t.co/kx2EEQMg1j